Unknown

Dataset Information

Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces.


ABSTRACT: Antibody-mediated delivery of immunogenic viral CD8+ T-cell epitopes to redirect virus-specific T cells toward cancer cells is a promising new therapeutic avenue to increase the immunogenicity of tumors. Multiple strategies for viral epitope delivery have been shown to be effective. So far, most of these have relied on a free C-terminus of the immunogenic epitope for extracellular delivery. Here, we demonstrate that antibody-epitope conjugates (AECs) with genetically fused epitopes to the N-terminus of the antibody can also sensitize tumors for attack by virus-specific CD8+ T cells. AECs carrying epitopes genetically fused at the N-terminus of the light chains of cetuximab and trastuzumab demonstrate an even more efficient delivery of the T-cell epitopes compared to A

SUBMITTER: van der Wulp W 

PROVIDER: S-EPMC10950288 | biostudies-literature | 2024 Jan-Dec

REPOSITORIES: biostudies-literature